Strategic Overview of Global Preventable Vaccine Market 2012-2016

世界の予防ワクチン市場動向(2012-2016)

◆タイトル:Strategic Overview of Global Preventable Vaccine Market 2012-2016
◆商品コード:IRTNTR2076
◆調査・発行会社:Technavio (Infiniti Research Ltd.)
◆発行日:2013年4月12日
◆ページ数:111
◆資料形式:pdf / 英語
◆納品方法:Eメール
◆調査対象地域:グローバル
◆販売価格オプション(消費税別)
Single UserUSD3,000 ⇒換算¥324,000見積依頼/購入/質問フォーム
Five UserUSD3,300 ⇒換算¥356,400見積依頼/購入/質問フォーム
Enterprise License(社内共有可)USD4,000 ⇒換算¥432,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※商品の納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。(振込先:三菱東京UFJ銀行/京橋支店/H&Iグローバルリサーチ株式会社)
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※ご購入後、資料に記載の英語表現や単語の意味に関しましては無料でお答えいたします。(但し、対応範囲は弊社で判断)
※弊社H&Iグローバルリサーチ株式会社はTechnavio (Infiniti Research Ltd.)の日本における正規販売代理店です。

【資料の概要】

本調査レポートでは、"世界の予防ワクチン市場動向(2012-2016)"について調査・分析し、エグゼクティブサマリー、市場概観、市場規模及び予測、主要地域別分析、購買基準、市場成長要因、市場の課題、市場動向、主要企業(ベンダー)分析等の情報をお届けいたします。

TechNavio’s analysts forecast the Strategic Overview of Global Preventable Vaccine Market to grow at a CAGR of 8.99 percent over the period 2012-2016. One of the key factors contributing to this market growth is the increase in demand for vaccination. The Strategic Overview of Global Preventable Vaccine market has also been witnessing the trend of increase in market consolidation. However, the emergence of regional players could pose a challenge to the growth of this market.

TechNavio’s report, the Strategic Overview of Global Preventable Vaccine Market 2012-2016, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers Americas, and the EMEA and APAC regions; it also covers the Strategic Overview of Global Preventable Vaccine Market landscape and its growth prospects in the coming years. The report also includes a discussion of the key vendors operating in this market.

Key vendors dominating this space include GlaxoSmithKline plc. Sanofi Pasteur SA, Merck & Co. Inc., Novartis AG, Pfizer Inc., Emergent BioSolutions Inc .

Key questions answered in this report:
What will the market size be in 2016 and at what will be the growth rate?
What are key market trends?
What is driving this market?
What are the challenges to market growth?
Who are the key vendors in this market space?
What are the market opportunities and threats faced by key vendors?
What are the strengths and weaknesses of each of these key vendors?

You can request one free hour of our analyst’s time when you purchase this market report. Details provided within the report.

【資料の目次】

01. Executive Summary
02. List of Abbreviations
03. Introduction
04. Market Research Methodology
Market Research Process
Research Design
Research Methodology
05. Scope of the Report
Market Overview
Product Offerings
06. Vaccine
06.1 Introduction
06.2 Types of Vaccines
Live Attenuated (weakened) Vaccine
Killed (inactivated) Vaccine
Toxoid Vaccine
Genetically Modified/Engineered Vaccine
06.3 Subunit Vaccines
06.4 Conjugate Vaccines
06.5 DNA Vaccines
06.6 Recombinant Vector Vaccines
06.7 Vaccine Approval Process
07. Global Preventable Vaccines Market
07.1 Market Size and Forecast
07.2 Global Preventable Vaccine Market Segmentation
07.3 Global Preventable Vaccine Market Share by Vaccine Type 2012
07.4 Global Preventable Vaccine Market by Revenue 2012-2016(US$ billions)
08. Competitive Landscape of Global Preventable Vaccine Market
08.1 Global Preventable Vaccine Market Share by Vendor 2012
08.2 Global Preventable Vaccine Market Share by Vaccine Type 2016
08.3 Global Preventable Vaccine Market Share by Vaccine Type 2012-2016
09. Geographical Analysis of Global Preventable Vaccines Market
09.1 Market Size and Forecast for the US
09.2 Market Size and Forecast for EU
09.3 Market Size and Forecast for Japan
09.4 Market Size and Forecast for India
09.5 Market Size and Forecast for China
09.6 Market Size and Forecast for ROW
10. Global Pediatric Preventable Vaccines Market
10.1 Global Pediatric Preventable Vaccines Market
Market Size and Forecast
10.2 Market Segmentation of Global Pediatric Preventable Vaccine
10.3 Global Pediatric Hepatitis Vaccine Market
Market Size and Forecast
10.4 Global Pediatric Haemophilus Influenzae Type B (Hib) Vaccine Market
Market Size and Forecast
10.5 Global Pediatric Measles, Mumps and Rubella (MMR) Vaccine Market
Market Size and Forecast
10.6 Global Pediatric Combination Vaccines Market
Market Size and Forecast
10.7 Global Pediatric Pneumococcal Vaccine Market
Market Size and Forecast
10.8 Global Polio Vaccine Market
Market Size and Forecast
10.9 Global Pediatric Varicella Vaccine Market
Market Size and Forecast
10.10 Global Other Pediatric Vaccine Market
Market Size and Forecast
10.11 Global Pediatric Preventable Vaccine Market 2012-2016 (Percentage)
11. Pipeline Assessment of Pediatric Preventable Vaccine Market
12. Competitive Landscape of Global Pediatric Preventable Vaccine Market
12.1 Global Pediatric Preventable Vaccine Market Share by Vendor 2012
12.2 Global Pediatric Preventable Vaccine Market Share by Vaccine Type 2012
12.3 Global Pediatric Preventable Vaccine Market Share by Vaccine Type 2016
13. Geographical Segmentation of Pediatric Preventable Vaccine Market
14. Global Pediatric Preventable Vaccines Market by Regions
14.1 Market Size and Forecast for the US
14.2 Market Size and Forecast for EU
14.3 Market Size and Forecast for Japan
14.4 Market Size and Forecast for India
14.5 Market Size and Forecast for China
14.6 Market Size and Forecast for ROW
15. Global Adult Preventable Vaccines Market
15.1 Global Adult Preventable Vaccines Market
Market Size and Forecast
15.2 Market Segmentation of Global Adult Preventable Vaccine
15.3 Global Cervical Vaccine Market
Market Size and Forecast
15.4 Global Hepatitis Vaccine Market
Market Size and Forecast
15.5 Global Influenza Vaccine Market
Market Size and Forecast
15.6 Global Adult Pneumococcal Vaccine Market
Market Size and Forecast
15.7 Global Travel, Diphtheria-Tetanus, Miscellaneous Vaccine Market
Market Size and Forecast
16. Pipeline Assessment of Adult Preventable Vaccine Market
17. Competitive Landscape of Global Adult Preventable Vaccine Market
17.1 Global Adult Preventable Vaccine Market Share by Vendor 2012
17.2 Global Adult Preventable Vaccine Market Share by Vaccine Type 2012
17.3 Global Adult Preventable Vaccine Market Share by Vaccine Type 2016
18. Geographical Segmentation of Adult Preventable Vaccine Market
19. Global Adult Preventable Vaccines Market by Regions
19.1 Market Size and Forecast for US
19.2 Market Size and Forecast for EU
19.3 Market Size and Forecast for Japan
19.4 Market Size and Forecast for India
19.5 Market Size and Forecast for China
19.6 Market Size and Forecast for ROW
20. Buying Criteria
21. Market Growth Drivers
22. Drivers and their Impact
23. Market Challenges
24. Impact of Drivers and Challenges
25. Market Trends
26. Key Vendor Analysis
26.1 Sanofi Pasteur SA
Business Overview
Key Information
SWOT Analysis
26.2 GlaxoSmithKline plc.
Business Overview
Key Information
SWOT Analysis
26.3 Pfizer Inc.
Business Overview
Key Information
SWOT Analysis
26.4 Novartis AG
Business Overview
Key Information
SWOT Analysis
26.5 Merck & Co. Inc.
Business Overview
Key Information
SWOT Analysis
26.6 Emergent BioSolutions Inc.
Business Overview
Key Information
SWOT Analysis
27. Other Reports in this Series

List of Exhibits
Exhibit 1: Market Research Methodology
Exhibit 2: Categorization of Global Preventable Vaccine Market
Exhibit 3: Vaccine Approval Process
Exhibit 4: Global Preventable Vaccines Market 2012-2016 (US$ billions)
Exhibit 5: Preventable Vaccines market in US 2012-2016 (US$ billions)
Exhibit 6: Preventable Vaccines market in EU 2012-2016 (US$ billions)
Exhibit 7: Preventable Vaccines market in Japan 2012-2016 (US$ billions)
Exhibit 8: Preventable Vaccines market in India 2012-2016 (US$ billions)
Exhibit 9: Preventable Vaccines market in China 2012-2016 (US$ billions)
Exhibit 10: Preventable Vaccines market in ROW 2012-2016 (US$ billions)
Exhibit 11: Geographical Analysis of Global Preventable Vaccines Market 2012-2016 (US$ billions)
Exhibit 12: Geographical Analysis of Global Preventable Vaccines Market 2012-2016 (CAGR values)
Exhibit 13: Global Pediatric Preventable Vaccines Market 2012-2016 (US$ billions)
Exhibit 14: Global Pediatric Hepatitis Vaccine Market 2012-2016 (US$ billions)
Exhibit 15: Global Pediatric Haemophilus Influenzae Type B Market 2012-2016 (US$ billions)
Exhibit 16: Global Pediatric Measles, Mumps and Rubella (MMR) Vaccine Market 2012-2016 (US$ billions)
Exhibit 17: Global Pediatric Combination Vaccines Market 2012-2016 (US$ billions)
Exhibit 18: Global Pediatric Pneumococcal Vaccine Market 2012-2016 (US$ billions)
Exhibit 19: Global Polio Vaccine Market 2012-2016 (US$ billions)
Exhibit 20: Global Pediatric Varicella Vaccine Market 2012-2016 (US$ billions)
Exhibit 21: Global Other Pediatric Vaccine Market 2012-2016 (US$ billions)
Exhibit 22: Global Pediatric Preventable Vaccine Market by Geographical Segmentation 2012
Exhibit 23: Pediatric Preventable Vaccines market in US 2012-2016 (US$ billions)
Exhibit 24: Pediatric Preventable Vaccines market in EU 2012-2016 (US$ billions)
Exhibit 25: Pediatric Preventable Vaccines market in Japan 2012-2016 (US$ billions)
Exhibit 26: Pediatric Preventable Vaccines market in India 2012-2016 (US$ billions)
Exhibit 27: Pediatric Preventable Vaccines market in China 2012-2016 (US$ billions)
Exhibit 28: Pediatric Preventable Vaccines market in ROW 2012-2016 (US$ billions)
Exhibit 29: Global Adult Preventable Vaccines Market 2012-2016 (US$ billions)
Exhibit 30: Global Cervical Vaccine Market 2012-2016 (US$ billions)
Exhibit 31: Global Hepatitis Vaccine Market 2012-2016 (US$ billions)
Exhibit 32: Global Influenza Vaccine Market 2012-2016 (US$ billions)
Exhibit 33: Global Adult Pneumococcal Vaccine Market 2012-2016 (US$ billions)
Exhibit 34: Global Travel, Diphtheria-Tetanus, Miscellaneous Vaccine Market 2012-2016 (US$ billions)
Exhibit 35: Global Adult Preventable Vaccine Market by Geographical Segmentation 2012
Exhibit 36: Adult Preventable Vaccines market in US 2012-2016 (US$ billions)
Exhibit 37: Adult Preventable Vaccines market in EU 2012-2016 (US$ billions)
Exhibit 38: Adult Preventable Vaccines market in Japan 2012-2016 (US$ billions)
Exhibit 39: Adult Preventable Vaccines market in India 2012-2016 (US$ billions)
Exhibit 40: Adult Preventable Vaccines market in China 2012-2016 (US$ billions)
Exhibit 41: Adult Preventable Vaccines market in ROW 2012-2016 (US$ billions)



【掲載企業】

GlaxoSmithKline plc. Sanofi Pasteur SA, Merck & Co. Inc., Novartis AG, Pfizer Inc., Emergent BioSolutions Inc .

【調査方法】

一次資料による調査(業界専門家、ベンダー、代理店、顧客等を対象にしたデプスインタビュー調査など)及び二次資料による調査(Technavio独自のプラットフォーム、産業書籍、企業報告書、ニュース記事、アナリストレポート、貿易協会、政府機関発行データなど)

★調査レポート[世界の予防ワクチン市場動向(2012-2016)] (Strategic Overview of Global Preventable Vaccine Market 2012-2016 / IRTNTR2076)販売に関する免責事項
[世界の予防ワクチン市場動向(2012-2016)] (Strategic Overview of Global Preventable Vaccine Market 2012-2016 / IRTNTR2076)についてEメールでお問い合わせ


◆H&Iグローバルリサーチ株式会社のお客様(例)◆